Nutrien Ltd. $NTR Shares Bought by BCS Private Wealth Management Inc.

Key Points

• BCS Private Wealth Management increased its stake in Nutrien by 501.5% in Q4, buying an additional 54,955 shares to hold 65,913 shares worth about $4.10 million (1.4% of its portfolio, the firm's 21st largest position).
• Nutrien reported Q4 EPS of $0.83 (vs. $0.87 consensus) and revenue of $5.12 billion (vs. $5.26 billion expected), with revenue up 5.1% year‑over‑year.
• The company declared a quarterly dividend of $0.55 per share payable April 16 (record March 31), implying an annualized payout of $2.20 and a yield of about 3.0%.

BCS Private Wealth Management Inc. grew its holdings in shares of Nutrien Ltd. (NYSE:NTR - Free Report) by 501.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 65,913 shares of the company's stock after purchasing an additional 54,955 shares during the period. Nutrien accounts for 1.4% of BCS Private Wealth Management Inc.'s portfolio, making the stock its 21st biggest position. BCS Private Wealth Management Inc.'s holdings in Nutrien were worth $4,104,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Root Financial Partners LLC bought a new position in shares of Nutrien during the third quarter worth about $37,000. Eastern Bank grew its position in shares of Nutrien by 133.0% during the fourth quarter. Eastern Bank now owns 699 shares of the company's stock worth $43,000 after acquiring an additional 399 shares during the last quarter. Geneos Wealth Management Inc. grew its position in shares of Nutrien by 42.4% during the second quarter. Geneos Wealth Management Inc. now owns 735 shares of the company's stock worth $43,000 after acquiring an additional 219 shares during the last quarter. Fulcrum Asset Management LLP bought a new position in shares of Nutrien during the third quarter worth about $46,000. Finally, Bessemer Group Inc. grew its position in shares of Nutrien by 27.7% during the third quarter. Bessemer Group Inc. now owns 937 shares of the company's stock worth $55,000 after acquiring an additional 203 shares during the last quarter. 63.10% of the stock is owned by institutional investors and hedge funds.

Nutrien Stock Performance

NYSE:NTR opened at $73.65 on Wednesday. Nutrien Ltd. has a twelve month low of $51.98 and a twelve month high of $85.36. The company has a current ratio of 1.34, a quick ratio of 0.70 and a debt-to-equity ratio of 0.37. The company has a 50-day moving average of $74.32 and a 200-day moving average of $65.50. The firm has a market cap of $35.43 billion, a price-to-earnings ratio of 15.80 and a beta of 0.69.

Nutrien (NYSE:NTR - Get Free Report) last posted its quarterly earnings data on Wednesday, February 18th. The company reported $0.83 earnings per share for the quarter, missing the consensus estimate of $0.87 by ($0.04). Nutrien had a net margin of 8.43% and a return on equity of 8.41%. The business had revenue of $5.12 billion for the quarter, compared to the consensus estimate of $5.26 billion. During the same quarter last year, the business posted $0.31 EPS. The business's revenue for the quarter was up 5.1% on a year-over-year basis. Analysts forecast that Nutrien Ltd. will post 3.72 earnings per share for the current fiscal year.

Nutrien Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 16th. Shareholders of record on Tuesday, March 31st will be paid a dividend of $0.55 per share. This is a boost from Nutrien's previous quarterly dividend of $0.55. This represents a $2.20 dividend on an annualized basis and a yield of 3.0%. The ex-dividend date of this dividend is Tuesday, March 31st. Nutrien's payout ratio is currently 47.21%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on NTR shares. Raymond James Financial upped their price target on shares of Nutrien from $68.00 to $74.00 and gave the stock a "market perform" rating in a research report on Friday, February 20th. Bank of America upped their price target on shares of Nutrien from $75.00 to $81.00 and gave the stock a "neutral" rating in a research report on Wednesday, March 18th. Mizuho increased their target price on shares of Nutrien from $65.00 to $68.00 and gave the company a "neutral" rating in a research report on Friday, January 16th. JPMorgan Chase & Co. increased their target price on shares of Nutrien from $68.00 to $78.00 and gave the company an "overweight" rating in a research report on Friday, February 20th. Finally, UBS Group lowered shares of Nutrien from a "neutral" rating to a "sell" rating and increased their target price for the company from $63.00 to $67.00 in a research report on Thursday, March 26th. Ten research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $79.65.

Nutrien Profile

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien's business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.